Ross Acquisition Corp II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded in 2021 and is based in Palm Beach, Florida.
IPO Year: 2021
Exchange: NYSE
Website: rossacquisition2.com
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
3/A - Ross Acquisition Corp II (0001841610) (Issuer)
25-NSE - Ross Acquisition Corp II (0001841610) (Subject)
8-K - Ross Acquisition Corp II (0001841610) (Filer)
8-K - Ross Acquisition Corp II (0001841610) (Filer)
DEFA14A - Ross Acquisition Corp II (0001841610) (Filer)
DEFA14A - Ross Acquisition Corp II (0001841610) (Filer)
8-K - Ross Acquisition Corp II (0001841610) (Filer)
PRE 14A - Ross Acquisition Corp II (0001841610) (Filer)
10-Q - Ross Acquisition Corp II (0001841610) (Filer)
NT 10-Q - Ross Acquisition Corp II (0001841610) (Filer)
10-Q - Ross Acquisition Corp II (0001841610) (Filer)
Fastest customizable press release news feed in the world
PALM BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- Ross Acquisition Corp II (NYSE:ROSS) (the "Company" or "we"), a special purpose acquisition company, announced today that the New York Stock Exchange (the "NYSE") notified the Company that it plans to suspend trading of the Company's Class A ordinary shares, public warrants and public units before market open today and commence delisting proceedings with respect to such securities. The NYSE determined to take these actions because Sections 102.06e and 802.01B of the NYSE's Listed Company Manual do not permit a special purpose acquisition company, such as the Company, to remain listed for more than three years after the company's initial
PALM BEACH, Fla., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Ross Acquisition Corp II (NYSE:ROSS) (the "Company") announced that on February 26, 2024 it filed a definitive proxy statement (the "Definitive Proxy Statement") for the solicitation of proxies in connection with an extraordinary general meeting (the "Extraordinary General Meeting") of the Company's shareholders to be held on March 6, 2024 to consider and vote on, among other proposals, an amendment to the Company's Amended and Restated Memorandum and Articles of Association, to extend the date by which the Company must consummate a business combination from March 16, 2024 to September 16, 2024 (such proposal, the "Extension Amendment Pro
PALM BEACH, Fla., Sept. 15, 2023 (GLOBE NEWSWIRE) -- Ross Acquisition Corp II (NYSE:ROSS) (the "Company") announced today that its shareholders approved amendments to the Company's Amended and Restated Memorandum and Articles of Association to, amongst other things, extend the date by which the Company must consummate a business combination from September 16, 2023 to March 16, 2024 (such proposal, the "Extension Amendment Proposal"). In connection with the vote to approve the Extension Amendment Proposal, the holders of 1,339,804 Class A ordinary shares of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.74 per share, fo
PALM BEACH, Fla., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Ross Acquisition Corp II (NYSE:ROSS) (the "Company") announced that on August 31, 2023 it filed a definitive proxy statement (the "Definitive Proxy Statement") for the solicitation of proxies in connection with an extraordinary general meeting in lieu of annual general meeting (the "Extraordinary General Meeting") of the Company's shareholders to be held on September 15, 2023 to consider and vote on, among other proposals, an amendment to the Company's Amended and Restated Memorandum and Articles of Association, to extend the date by which the Company must consummate a business combination from September 16, 2023 to March 16, 2024 (such
PALM BEACH, Fla., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Ross Acquisition Corp II (NYSE:ROSS) (the "Company") announced today that it received a notice (the "Notice") on August 22, 2023 from the NYSE Regulation staff of the New York Stock Exchange (the "NYSE") stating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual (the "Rule") because it has not timely filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the "Form 10-Q") with the Securities and Exchange Commission (the "SEC"). The Rule requires listed companies to timely file all required periodic financial reports with the SEC. The Notice has no immediate effect on the listi
ROSS SPAC will issue $280 million of stock for APRINOIA Therapeutics Precision Neurology Company Focused on Developing a Pipeline of Highly Specific Central Nervous System ("CNS") Diagnostics and Therapeutics, including CNS Protein Degraders Anticipated Proceeds From Transaction Expected to Finance Several Key Therapeutic and Diagnostic Programs to Data Announcements Business Combination is Expected to be Completed in 1H 2023 and the Combined Company is Expected to be traded on Nasdaq or NYSE upon Closing PALM BEACH, Fla. and CAMBRIDGE, Mass., Jan. 18, 2023 /PRNewswire/ -- APRINOIA Therapeutics Inc. ("APRINOIA"), a clinical-stage biotechnology company focused on neurodegenerative diseases su
PALM BEACH, Fla., May 27, 2021 /PRNewswire/ -- Ross Acquisition Corp II (NYSE:ROSS) (the "Company") today announced that it has regained compliance with Section 802.01E of the New York Stock Exchange ("NYSE") Listed Company Manual (the "Rule") after filing its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the "Form 10-Q") with the Securities and Exchange Commission (the "SEC") on May 27, 2021. On May 25, 2021, the Company received a notice (the "Notice") from the NYSE indicating that the Company was not in compliance with the Rule because it had not timely filed its Form 10-Q with the SEC as required by the Rule. The Notice had no immediate effect on the listing of th
This live feed shows all institutional transactions in real time.
SC 13G/A - Ross Acquisition Corp II (0001841610) (Subject)
SC 13G - Ross Acquisition Corp II (0001841610) (Subject)
SC 13G/A - Ross Acquisition Corp II (0001841610) (Subject)
SC 13G - Ross Acquisition Corp II (0001841610) (Subject)
SC 13G - Ross Acquisition Corp II (0001841610) (Subject)
SC 13G/A - Ross Acquisition Corp II (0001841610) (Subject)
SC 13G - Ross Acquisition Corp II (0001841610) (Subject)
SC 13G - Ross Acquisition Corp II (0001841610) (Subject)
SC 13G/A - Ross Acquisition Corp II (0001841610) (Subject)
SC 13G - Ross Acquisition Corp II (0001841610) (Subject)